New England Journal of Medicine Publishes Positive Data of Litifilimab in Cutaneous Lupus Erythematosus
August, 2022
We are pleased to share positive results from the two-part Phase 2 LILAC study published in the New England...
News
Lupus Research Alliance designa a Albert Roy como presidente y director ejecutivo
NUEVA YORK, NY. 10 de agosto de 2022. Lupus Research Alliance (LRA) se complace en anunciar el nombramiento de...
Lupus Research Alliance Appoints Albert Roy as President and Chief Executive Officer
NEW YORK, NY. August 10, 2022 – The Lupus Research Alliance (LRA) is pleased to announce the appointment of...
Researchers Discover How Gut Bacteria Can Trigger Autoimmunity
August 4, 2022
Immunologists have found that a certain gut bacteria escapes from the intestines to trigger inflammation that can...
LRA Congratulates GSK on FDA Approval of Benlysta® (belimumab) for Children with Lupus Nephritis
NEW YORK, NY. July 27, 2022. The Lupus Research Alliance (LRA) is pleased to share that the U.S. Food...
Walk to Make a Difference for People with Lupus
July 25, 2022
During a time when health and wellness are top of mind, many are looking for creative ways...
Overcoming the Uncertainties of Living with Chronic Diseases like Lupus
July 21, 2022
Interview with Michael D. Lockshin, MD, MACR
Director Emeritus, Barbara Volcker Center for Women and Rheumatic Disease and...
Study Finds Booster Vaccine Significantly Lowered COVID-19 Infection Risk Among People with Lupus
July 14, 2022
The booster dose of the SARS-CoV-2 vaccine significantly enhanced the degree of protection from COVID-19 infections for...
Lupus Research Alliance Awards 2022 Lupus Insight Prize to Immunologist Dr. Akiko Iwasaki: Renowned immunology expert honored
June 23, 2022
The Lupus Research Alliance (LRA) is pleased to award its 2022 Lupus Insight Prize (LIP) to Akiko...
Wise Words During Men’s Health Month
June 15, 2022
It took years for Dan Baruah aka ‘Dan the Man’ to come to terms with having lupus....
LRA Announces Inaugural Awards Promoting Diversity in Lupus Research
NEW YORK, NY, June 9, 2022. The Lupus Research Alliance (LRA), the world’s leading private funder of lupus research,...
LRA Brings Encouraging News from European Rheumatology Meeting
June 2, 2022
The Lupus Research Alliance (LRA) and its clinical trial arm Lupus Therapeutics congratulate Bristol Myers Squibb (BMS)...